
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Study Phase : Discovery Platform
Sponsor : Axcelead
Deal Size : Undisclosed
Deal Type : Collaboration
xFOREST and Axcelead DDP Launch Joint Research on Small Molecule Drug Discovery
Details : The collaboration aims at developing RNA structure-targeted small molecule therapeutics for multiple diseases.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Undisclosed
September 19, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Highest Development Status : Discovery Platform
Sponsor : Axcelead
Deal Size : Undisclosed
Deal Type : Collaboration

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Study Phase : Discovery Platform
Sponsor : Otsuka Pharmaceutical
Deal Size : Undisclosed
Deal Type : Collaboration
Details : Under the agreement, xFOREST will provide Otsuka with FOREST technologies to promote systemic, small-molecule drug discovery research targeting RNA structures. Otsuka will have exclusive rights to develop and commercialize RNA-targeted small molecules.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
June 13, 2022
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Highest Development Status : Discovery Platform
Sponsor : Otsuka Pharmaceutical
Deal Size : Undisclosed
Deal Type : Collaboration
